ZSAN

Zosano Pharma News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Zosano Pharma Corporation ZSAN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0053 0.76% 0.6998 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.6838 0.666 0.695 0.7063 0.6945
more quote information »

Recent News

Date Time Source Heading
9/16/20218:07IHNWFeaturedFandom Sports Appoints Lyle Strachan as Chief Financial Officer
9/16/202111:39IHNWFeaturedNeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
9/02/202116:30GLOBEZosano Pharma to Present at the H.C. Wainwright Virtual ..
8/10/202116:05GLOBEZosano Pharma Reports Second Quarter 2021 Financial Results
8/10/202116:02EDGARCurrent Report Filing (8-k)
7/20/202108:51SEEKZosano Pharma granted patent related to migraine treatment..
7/20/202108:30GLOBEZosano Pharma Announces Issuance of U.S. Patent for Method..
7/15/202106:30EDGARNotice of Effectiveness (effect)
7/02/202117:17EDGARCurrent Report Filing (8-k)
7/02/202117:07EDGARSecurities Registration Statement (simplified Form) (s-3)
6/28/202116:17EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/21/202116:09EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/21/202116:07EDGARCurrent Report Filing (8-k)
6/10/202116:09EDGARCurrent Report Filing (8-k)
6/07/202118:44EDGARStatement of Changes in Beneficial Ownership (4)
6/07/202118:44EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202116:20EDGARCurrent Report Filing (8-k)
5/26/202116:23SEEKData supports long-term benefit of Zosano's migraine..
5/26/202116:05GLOBEZosano Pharma Announces Publication of Clinical Data..
5/25/202118:30EDGARStatement of Changes in Beneficial Ownership (4)
5/25/202118:11EDGARInitial Statement of Beneficial Ownership (3)
5/25/202116:13EDGARCurrent Report Filing (8-k)
5/25/202116:05GLOBEZosano Appoints Industry Veteran, Kathy McGee, to its Board..
5/18/202119:46EDGARStatement of Changes in Beneficial Ownership (4)
5/12/202116:39SEEKZosano Pharma EPS in-line
5/12/202116:25EDGARQuarterly Report (10-q)
5/12/202116:05GLOBEZosano Pharma Reports First Quarter 2021 Financial Results
5/12/202116:03EDGARCurrent Report Filing (8-k)
4/28/202116:05EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/26/202108:35SEEKZosano shares rise on migraine treatment NDA resubmission..
4/26/202108:10EDGARCurrent Report Filing (8-k)
4/26/202108:00GLOBEZosano Pharma Confirms Plan to Move Forward with..
4/13/202116:34EDGARCurrent Report Filing (8-k)
3/19/202118:13EDGARStatement of Changes in Beneficial Ownership (4)
3/12/202116:41EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/11/202117:20SEEKZosano Pharma EPS beats by $0.01
3/11/202116:23EDGARCurrent Report Filing (8-k)
3/11/202116:14EDGARAnnual Report (10-k)
3/11/202116:11EDGARCurrent Report Filing (8-k)
3/11/202116:05GLOBEZosano Pharma Reports Fourth Quarter and Fiscal Year 2020..
3/04/202116:07EDGARCurrent Report Filing (8-k)
3/02/202108:30GLOBEZosano Pharma to Present at the H.C. Wainwright Global Life..
2/22/202111:50SEEKZosano Pharma confirms NDA resubmission strategy for Qtrypta
2/22/202108:38EDGARCurrent Report Filing (8-k)
2/22/202108:30GLOBEZosano Pharma Confirms NDA Resubmission Strategy Following..
2/01/202108:30GLOBEZosano Pharma Presents Early-Onset of Action Data for..
2/01/202108:12EDGARCurrent Report Filing (8-k)
2/01/202108:00GLOBEZosano Pharma Announces NDA Resubmission Plans Following..
1/06/202116:17EDGARCurrent Report Filing (8-k)
1/05/202107:59EDGARAmended Statement of Ownership (sc 13g/a)
1/04/202116:05GLOBEZosano Pharma Requests Type A Meeting with the FDA to ..
1/04/202108:30GLOBEZosano Pharma to Present at the H.C. Wainwright Virtual..
See more news about this stock »


Your Recent History
NASDAQ
ZSAN
Zosano Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.